Erratum to: COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients.
Acta Neurochir (Wien)
; 159(1): 13, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27830324
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Acta Neurochir (Wien)
Year:
2017
Document type:
Article